Symrise, Shares

Symrise Shares: Analyst Targets and Market Performance Diverge

17.03.2026 - 05:47:56 | boerse-global.de

Symrise advances share buybacks as analysts debate outlook. Stock trades 31% below high, with recovery hopes pinned on H2 performance and shareholder returns.

Symrise Shares: Analyst Targets and Market Performance Diverge - Foto: über boerse-global.de
Symrise Shares: Analyst Targets and Market Performance Diverge - Foto: über boerse-global.de

A subdued start to the year, ongoing share repurchases, and a divided analyst community highlight a notable gap between expectations and the current business momentum at Symrise. The central question for investors is whether the company's performance in the second half of the year can bridge this divide.

Share Buyback Program Gains Momentum

The flavor and fragrance specialist continues to advance its current share repurchase initiative. During the week of March 9th to 13th, Symrise acquired 141,747 of its own shares at an average price of €71.53, representing a total investment of approximately €10.1 million. Since the program's commencement on February 2nd, the cumulative buyback now stands at nearly 970,000 shares.

This strategy, combined with a recently increased dividend, provides underlying support for the equity's valuation. Nevertheless, the share price remains significantly below its former levels, currently trading at a discount of roughly 31% to its 52-week high of €106.55. Market participants await the second-quarter results to see if the anticipated acceleration in business will materialize later this year, making the stock one for patient investors in the interim.

Mixed Signals from Research Firms

Analyst opinions on Symrise's outlook present a contrasting picture. JPMorgan maintains an "Overweight" rating and a price target of €100, even after slightly reducing its growth forecasts for 2026. The bank acknowledges that Q1 results fell short of expectations but anticipates a recovery as the year progresses.

Should investors sell immediately? Or is it worth buying Symrise?

Adopting a more cautious stance, Berenberg has raised its price objective to €81.20 while keeping its "Hold" recommendation in place. The consensus average price target across all covering analysts is around €95, which sits well above the current trading level of approximately €74 per share.

Financial Expectations and Shareholder Returns

For the 2025 fiscal year, Symrise has reported an adjusted earnings per share figure of €3.67. The company has raised its dividend to €1.25 per share, and market experts forecast a further increase for 2026. The interplay between these shareholder return mechanisms and the company's fundamental operational performance will likely dictate the stock's trajectory in the coming months.

Ad

Symrise Stock: New Analysis - 17 March

Fresh Symrise information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Symrise analysis...

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
DE000SYM9999 | SYMRISE | boerse | 68698586 |